Owner Scorecard


← All companies ← PRME Manual PROK → ← PRCT Medical Devices & Equipment QTEX →

PROF, Profound Medical Corp.

Medical Devices & Equipment consumer brand UnprofitableDistress / turnaroundNet current asset value

We are a commercial-stage medical device company focused on the development and marketing of AI-powered, MRI-guided, incision-free therapies for the ablation of diseased tissue utilizing our platform technologies.

Our lead product, the TULSA-PRO system, combines real-time MRI, robotically-driven transurethral sweeping action/thermal ultrasound and closed-loop temperature feedback control to ablate whole gland or physician defined region of malignant or benign prostate tissue.

The TULSA-PRO system has been shown in clinical and commercial settings to be an effective tool for physicians who are treating prostate diseases including cancer and other conditions such as benign prostatic hyperplasia (" BPH ").

Latest annual: FY2025 10-K
PROF · Profound Medical Corp.
I

The business

What it sells, where the money comes from, the kind of company it is.

Revenue · FY2025
$16M
+50.7% YoY
Vital signs · TTM
Cash & investments $38M
Cash burn · annual $36M
Runway 1.1 yrs

Next report By 11/13 · the 10-Q for the quarter ended late September · due within 45 days of period end · has filed ~38 days after · the wire records it on arrival

The business in brief

read the 10-K →

What this business is and what moves its needle, from its own SEC filings.

What it is
Revenue is Recurring - Non-Capital (60%) and Capital Equipment (40%).
Situation
Unprofitable. No meaningful revenue yet; the record is the cash on hand against the burn. Distress / turnaround. Thin interest coverage, or operating cash burned against real debt, across the record. The balance sheet carries this situation; the debt schedule sets the clock. Net current asset value. Current assets alone exceed every liability combined, and the surplus is most of the balance sheet: the shape Graham called a net-net.
What moves the needle
Operating margin has run around −310% through the cycle on a 66% gross margin, the operating line in the red even at its best — so the lever is whether the spending below the gross line can come down enough to clear a profit: revenue growth against the cost curve, and the cash runway until it does. Inventory runs near 54% of sales, so how fast it turns back into cash — and the risk of writing it down when demand softens — sits alongside the margin. Read this kind of business on the installed base and what follows it. On its own account, the filing leans hardest on pricing power & competition, set against the numbers in what the filing emphasizes, below.
Is it a good business?
Return on capital has rarely cleared the cost of capital (median −257%, above 15% in 0 of 3 years). Owner earnings, the cash-based check, have been thin too. This is price-taker territory, where the balance sheet and the cycle matter more than any multiple; the rest is in the 10-K.

Every line is arithmetic on the company's filings, shown in full in the sections below.

Where the money comes from

read the 10-K →

Recurring - Non-Capital is 60% of revenue, with Capital Equipment the other meaningful line at 40%.

Revenue by product line, FY2025
  • Recurring - Non-Capital60%$10M
  • Capital Equipment40%$6M
By geographyUnited States76%Canada19%Germany5%

From the segment footnote of the company's own 10-K. Shares are of total revenue; the profit bar shows each segment's share of segment operating profit, before unallocated corporate costs.

II

The record

Ten years of arithmetic, read across the cycle.

The record, 2023–2025

realized figures from each filing · older years to the left
2023’232024’242025’25TTMTTMJun 2026
Income statement
$7M$11M$16M$19MRevenueRevenue
$4M$7M$11M$14MGross profitGross prof.
60%66%71%72%Gross marginGross mgn
258%217%199%149%SG&A / revenueSG&A/rev
200%159%128%108%R&D / revenueR&D/rev
($29M)($33M)($41M)($35M)Operating incomeOp. inc.
−398.0%−309.6%−256.3%−185.3%Operating marginOp. mgn
($28M)($28M)($42M)Pretax incomePretax
($28M)($28M)($43M)($33M)Net incomeNet inc.
Cash flow & returns
($23M)($23M)($38M)($36M)Operating cash flowOp. cash
$727K$707K$373K$374KDepreciationDeprec.
$2M$1M($2M)($9M)Working capital & otherWC & other
$176K$176KCapexCapex
1.1%0.9%Capex / revenueCapex/rev
($38M)($36M)Owner earningsOwner earn.
−238.4%−190.1%Owner earnings marginOE mgn
($38M)($36M)Free cash flowFCF
−238.4%−190.1%Free cash flow marginFCF mgn
$2M$55M$41MFinancing cash flowFin. cash
$549K($3M)$2MExchange-rate effectFX
-187%-257%-291%-136%ROICROIC
-91%-46%-64%-66%Return on equityROE
−91%−46%−64%−66%Retained to equityRetained/eq
Balance sheet
$26M$55M$60M$38MCash & investmentsCash+inv
$7M$6M$8M$10MInventoryInvent.
$865K$1M$2M$955KAccounts payablePayables
$6M$4M$7M$10MOperating working capitalOper. WC
$42M$69M$76M$59MCurrent assetsCur. assets
$6M$7M$6M$9MCurrent liabilitiesCur. liab.
6.6×10.5×12.5×6.5×Current ratioCurr. ratio
$909K$425K$698KNet PP&ENet PP&E
$44M$70M$77M$62MTotal assetsAssets
$7M$5M$4M$9MTotal debtDebt
($19M)($50M)($55M)($29M)Net debt / (cash)Net debt
$13M$10M$11MTotal liabilitiesTotal liab.
$31M$60M$66M$50MShareholders’ equityEquity
47.5%24.2%34.1%26.1%Stock comp / revenueSBC/rev
Per share
21.2M24.8M30.2M36.3MShares out (diluted)Shares
$0.34$0.43$0.53$0.53Revenue / shareRev/sh
$-1.34$-1.12$-1.41$-0.90EPS (diluted)EPS
$-1.27$-1.00Owner earnings / shareOE/sh
$-1.27$-1.00Free cash flow / shareFCF/sh
$0.01$0.00Cap. spending / shareCapex/sh
$1.47$2.44$2.20$1.37Book value / shareBVPS

Net income is the accountant's number; owner earnings is the cash an owner could take out. The walk between them, off the cash-flow statement, and whether the gap is widening or holding.

In fiscal 2025 the business turned a $43M loss into ($38M) of owner earnings: more cash than the profit line showed, after the non-cash charges and the capital it put back in.

FY2025
Reported net income($43M)
Depreciationnon-cash charge added back+$373K
Amortization of intangible assetsnon-cash charge added back; the purchase price of past acquisitions, expensed over time+$187K
Stock-based compensationreal costnon-cash, but a real cost+$5M
Working capital & othertiming of cash in and out, other non-cash items−$2M
Cash from operations($38M)
Capital expenditurecash put back in to keep running and to grow−$176K
Owner earnings($38M)
Owner-earnings marginowner earnings ÷ revenue-238%

Owner earnings is the cash an owner could pull out without starving the business: operating cash less the capital it must spend to hold its position . The cash-flow statement also adds stock comp back as non-cash, but it is a real cost paid in shares; counted as the expense it is (less $5M), owner earnings is nearer ($44M).

Maintenance capex is estimated as depreciation where a growing business invests above it; free cash flow is the figure the scorecard's free-cash margin reads.

III

Quality & stewardship

Returns, the balance sheet, capital allocation, and pay.

Owner’s Scorecard

FY2025 10-K · source on SEC EDGAR →

Will it survive?

  • No meaningful interest burden
    Little or no interest expense reported
    What this means

    Little or no interest expense reported, the business isn't leaning on lenders to operate.

  • Net cash
    Cash $60M − debt $6M
    What this means

    Cash and short-term investments exceed every dollar of debt by $53M, on net the company owes nothing, and can act from strength when others can't. Net debt is the leverage figure that matters: the cash is already set against the debt. Strategic or illiquid investments aren't counted here.

  • Not enough data
    What this means

    The filing data didn't include the inputs for this check.

Is it a good business?

  • Below average through the cycle
    3-yr median, range -291%–-187%; -252% latest = NOPAT ($33M) ÷ invested capital $13M
    Industry peers: median -86%
    What this means

    The rate the business earns on the money tied up in it, Buffett's north star, because over time a stock tracks the ROIC beneath it. Above ~15% sustained hints at a moat; a return below the cost of capital (~8%) erodes value as a business grows rather than building it — the test Buffett weighs most. The headline is the median of the last 3 years (it ran -252% most recently), so one peak or trough year doesn't set the verdict. Asset-light businesses (R&D expensed, little capital) read artificially high, pair this with Owner Earnings.

  • Consumes cash
    Owner earnings ($38M) = operating cash ($38M) − maintenance capex $176K
    Industry peers: median -156%
    What this means

    What an owner could take out without starving the business: operating cash less the maintenance capital it must spend to hold its position — Buffett's owner earnings. That's -238% of revenue this year. Treating stock comp as the real expense it is (less $5M of SBC) leaves ($44M).

  • Loss, and burning cash
    Net income ($43M) · cash from operations ($38M)
    What this means

    The company reported a net loss, so a conversion ratio isn't meaningful. What matters then is whether operations still threw off cash, here, they did not.

How is the cash used?

  • Not enough data
    What this means

    The filing data didn't include the inputs for this check.

  • Investing or harvesting? 0.47×
    Harvesting
    Capex $176K ÷ property depreciation $373K
    What this means

    Descriptive, not a grade. Above ~1× means investing faster than assets wear out (growth, or, sustained for years, today's earnings carrying less depreciation than tomorrow's will). Below means spending less than it's wearing out (efficiency, or a melting asset base). The ratio won't tell you which; the filings will.

The promise and the pay packet

  • Is the buyback buying ownership, or mopping up? 34.1%
    The count is rising
    Stock compensation $5M (fiscal 2025), 34.1% of revenue · no repurchases · diluted shares +42.7% since 2023
    What this means

    Stock handed to employees is a real cost paid in the owner's own currency: it is charged against profit, but the shares it creates are permanent. Many companies repurchase stock at the same time, which looks like a return of capital and often is not — if the count barely moves, the cash merely cancelled the pay packet and bought the owner nothing. The three states worth telling apart are a count genuinely shrinking, a count standing still despite large repurchases, and a count rising because the issuance was never offset at all.

Graham’s defensive tests · 2 of 3 met

Graham’s numerical criteria for the defensive investor (The Intelligent Investor, ch. 14), run on the filings. A floor of safety, not a buy signal; many fine modern businesses fail his strictest liquidity rules by design.

  • Adequate size Miss
    Revenue ≥ $2B · $16M
    What this means

    Big enough to weather a storm. Graham's 1972 floor was ~$100M of sales (≈ $700M today); we use a $2B revenue line as a conservative modern stand-in.

  • Strong liquidity Pass
    Current ratio ≥ 2× · 12.52×
    What this means

    Current assets at least twice current liabilities, near-term bills covered without touching the business. Strict by design: many cash-rich modern firms run leaner and miss it, holding their cushion in longer-dated securities.

  • Conservative debt Pass
    Debt ≤ working capital · $6M vs $70M WC
    What this means

    Graham's rule that borrowings not exceed net current assets. Capital-heavy and buyback-heavy firms routinely fail it, read it next to interest coverage, not alone.

  • Moderate price
    P/E ≤ 15 and P/E × P/B ≤ 22.5 · decided by the price
    What this means

    Graham's valuation gate, the wall he kept between a sound business and a sound investment. Three-year average earnings are $-0.90/share (latest year $-1.17), the averaged base the calculator's gate runs on, and book value is $1.82/share. Enter a price in “What the price implies” just below for the P/E, P/B, and whether it clears. But this is the rule Buffett outgrew: there's no hard P/E law, and a wonderful business can deserve a far richer multiple if the thesis holds, treat it as the bargain-hunter's floor, not a verdict on the price.

All figures as filed; the source filing is linked above.

Current Position

as of the latest quarter, Jun 30, 2026

Can the business pay what it owes this year, off the freshest balance sheet: the quality of the assets, the debt actually coming due, and what a low ratio means here.

Current assets$59M
  • Cash & short-term investments$38M
  • Inventory$10M
  • Other current assets$10M
Current liabilities$9M
  • Debt due within a year$5M
  • Accounts payable$955K
  • Other current liabilities$4M
Current ratio6.46×all current assets ÷ what's due · Graham looked for 2×
Quick ratio5.31×stricter: inventory excluded
Cash ratio4.20×strictest: cash alone against what's due
Working capital$50Mthe cushion left after near-term bills
Debt due this year vs. cash$5M due · $38M cash covered by cash on hand, no refinancing forced · both figures from the Jun 30, 2026 balance sheet
Cash runway1.1 yrsthe business is consuming cash; this is how long the cash on hand lasts at that rate
Revenue, latest quarter vs. a year ago+25.3%the freshest read on whether the business is still growing
Current ratio, recent quarters10.5× → 6.5×
Deeper floors
Tangible book value$50Mequity stripped of goodwill & intangibles
Net current asset value$46MGraham's net-net: current assets less all liabilities
Debt incl. operating leases$12M$3M of it operating leases
Deferred revenue$960Kcustomer cash collected before delivery; operating float

From the company's latest filing.

Management, ownership & pay

From the proxy: how much of the business the people running it own, and how they are paid.

  • Stock-based compensation$5M

    The slice of the business handed to employees in shares in fiscal 2025, 34.1% of revenue. Buffett's oldest accounting fight: this is compensation, compensation is an expense, real whether or not the headline earnings admit it. One trap: the cash-flow statement adds SBC back, so the operating cash, and the owner earnings drawn from it, are flattered by exactly this amount; counted as the cost it is, what an owner keeps is lower.

What an owner would ask, FY2025

read the 10-K →
  • Which reported numbers are a judgment call?
    Management names Credit & receivables as critical estimates

    each rests partly on management's judgment; the filing's note sets out the assumptionsverify →

The questions the record and the charts do not answer on their own; each carries the figure and the place to look.

Peers, Medical Devices & Equipment

The same industry, side by side on owner economics. Each column names the period it is read over, and a median resting on fewer than three years carries that count beside it; the group median at the foot is the line to read each figure against.

CompanyRevenuelatest FY, USDGross marginmedian over the recordOp. marginmedian over the recordROICmedian over the recordOwner earn. marginmedian over the record
BWAYBrainsWay Ltd.$46M77%-26.5%-143%-26%
SSIISS Innovations International Inc.$42M27%-149.0%-86%-156%
CLPTClearPoint Neuro Inc.$37M63%-75.4%-228%-65%
BDMDBaird Medical Investment Holdings Limited$23M85%38.3%27%-14%
DRIODarioHealth Corp.$22M33%-257.7%-83%-192%
PROFProfound Medical Corp.$16M66%-309.6%-257%-238%1y
CVCapsoVision Inc.$14M54%2y-178.8%2y-152%1y-171%2y
NSPRInspireMD Inc.$9M21%-351.3%-85%-305%
Group median58%-163.9%-114%-163%
IV

The price

What a price has to assume.

What the price implies

reverse-DCF

Profound Medical Corp. is profitable, but owner earnings are negative this year because capital spending currently outruns operating cash, a build-out, so the owner-earnings reverse-DCF has no positive base to grow. We read the price from both ends instead: type a price to see the steady-state profitability it demands, then set the mature margin you would believe and weigh the two against each other. Nothing leaves your browser unless you enter it in your notebook.

$
The assumptions

Enter a price to run it.

Owner earnings it must reach
Margin the price demands
Owner-earnings margin today−190%

Two reads of one future. From your price: the owner earnings the company must reach, valued at a mature multiple and discounted back at your rate, expressed as the margin it implies on revenue grown at your rate. From your belief: the mature margin you would credit, set on the dial above. When the margin the price demands runs above the one you would believe, you are paying for a future taken on faith. For a deep cyclical at a trough, normalized through-cycle earnings are the better lens; this mode is for the genuinely unprofitable, and for the profitable business whose capital spending currently outruns its cash.

Cite: Owner Scorecard, "Profound Medical Corp. (PROF), the owner's record," https://ownerscorecard.com/c/PROF, data as of 2026-08-17.

Manual order: ← PRME its page in the Manual PROK →

Industry order: ← PRCT the Medical Devices & Equipment chapter QTEX →